$GATO
Gatos Silver, Inc.

2022 Q3 Form 10-Q Financial Statement

#000110465923038837 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.930M $4.260M $6.780M
YoY Change -1.07% -3.42% 88.33%
% of Gross Profit
Research & Development $0.00 $0.00 $110.0K
YoY Change -100.0% -100.0% -50.0%
% of Gross Profit
Depreciation & Amortization $40.00K $50.00K $40.00K
YoY Change 29.03% 1150.0% 300.0%
% of Gross Profit
Operating Expenses $5.977M $4.300M $6.930M
YoY Change -8.1% -15.88% 80.94%
Operating Profit
YoY Change
Interest Expense $8.790M $8.640M $6.730M
YoY Change 449.38% -52.76% 149.26%
% of Operating Profit
Other Income/Expense, Net $1.076M $1.110M $1.146M
YoY Change -1232.63% 255.77% -333.88%
Pretax Income $4.029M $5.571M $1.050M
YoY Change -126.86% -58.71% -164.81%
Income Tax $525.0K $340.0K
% Of Pretax Income 13.03% 6.1%
Net Earnings $1.900M -$2.426M $18.83M
YoY Change -112.67% -117.98% -1262.28%
Net Earnings / Revenue
Basic Earnings Per Share $0.03 -$0.04 $0.27
Diluted Earnings Per Share $0.03 -$0.04 $0.27
COMMON SHARES
Basic Shares Outstanding 69.16M 69.16M 69.16M
Diluted Shares Outstanding 69.31M 69.16M 69.31M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.30M $7.300M $5.300M
YoY Change 23.41% -75.34% -82.9%
Cash & Equivalents $15.27M $7.277M $5.284M
Short-Term Investments
Other Short-Term Assets $1.077M $2.222M $2.850M
YoY Change 1.8% 1.46% -13.64%
Inventory
Prepaid Expenses $387.0K $1.347M $2.219M
Receivables
Other Receivables
Total Short-Term Assets $16.93M $10.08M $8.764M
YoY Change 14.9% -72.91% -77.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $341.1M $342.6M $379.8M
YoY Change -13.34% 38.52% 67.98%
Other Assets $39.00K $48.00K $28.00K
YoY Change -4.88% 0.0% -72.0%
Total Long-Term Assets $371.5M $374.7M $379.8M
YoY Change -5.63% 51.46% 68.0%
TOTAL ASSETS
Total Short-Term Assets $16.93M $10.08M $8.764M
Total Long-Term Assets $371.5M $374.7M $379.8M
Total Assets $388.4M $384.8M $388.6M
YoY Change -4.89% 35.21% 46.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $887.0K $198.0K $330.0K
YoY Change 237.26% -46.34% 10.0%
Accrued Expenses $361.0K $618.0K $1.129M
YoY Change -62.2% -69.99% -62.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.300M $1.300M $2.600M
YoY Change -43.11% -65.62% -25.71%
LONG-TERM LIABILITIES
Long-Term Debt $12.70M $12.70M $12.70M
YoY Change 0.93%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.70M $12.70M $12.70M
YoY Change 0.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.300M $1.300M $2.600M
Total Long-Term Liabilities $12.70M $12.70M $12.70M
Total Liabilities $15.10M $14.00M $15.20M
YoY Change -9.18% 270.27% 334.29%
SHAREHOLDERS EQUITY
Retained Earnings -$172.6M -$174.5M -$172.0M
YoY Change 14.62% 28.7%
Common Stock $117.0K $117.0K $117.0K
YoY Change 0.0% 8.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $373.4M $370.7M $373.4M
YoY Change
Total Liabilities & Shareholders Equity $388.4M $384.8M $388.6M
YoY Change -4.89% 35.21% 46.26%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $1.900M -$2.426M $18.83M
YoY Change -112.67% -117.98% -1262.28%
Depreciation, Depletion And Amortization $40.00K $50.00K $40.00K
YoY Change 29.03% 1150.0% 300.0%
Cash From Operating Activities $7.990M $2.020M -$1.332M
YoY Change -205.15% -254.79% -79.79%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $30.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$30.00K $0.00
YoY Change -100.0% -98.92% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0% -100.0% -100.0%
NET CHANGE
Cash From Operating Activities 7.990M 2.020M -1.332M
Cash From Investing Activities 0.000 -30.00K 0.000
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 7.990M 1.990M -1.332M
YoY Change -146.43% -239.26% -98.88%
FREE CASH FLOW
Cash From Operating Activities $7.990M $2.020M -$1.332M
Capital Expenditures $0.00 $30.00K
Free Cash Flow $7.990M $1.990M
YoY Change -205.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001517006
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39649
dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
dei City Area Code
CityAreaCode
604
dei Local Phone Number
LocalPhoneNumber
424-0984
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
GATO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15269000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6616000
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
586000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1592000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1077000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
16932000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11766000
CY2022Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
371452000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
355310000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2022Q3 us-gaap Assets
Assets
388423000
CY2021Q4 us-gaap Assets
Assets
367111000
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2334000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12730000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12620000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
117000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545800000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
543829000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172558000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190861000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
373359000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
388423000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367111000
CY2021Q3 us-gaap Exploration Expense
ExplorationExpense
479000
us-gaap Exploration Expense
ExplorationExpense
110000
us-gaap Exploration Expense
ExplorationExpense
1397000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5933000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7244000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16967000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17758000
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
31000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
132000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
45000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
5977000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
7754000
us-gaap Costs And Expenses
CostsAndExpenses
17209000
us-gaap Costs And Expenses
CostsAndExpenses
19200000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6801000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1600000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
32180000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22592000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1076000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8845000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3332000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6520000
CY2022Q3 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
7877000
CY2021Q3 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-7245000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
35512000
gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
16072000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1900000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14999000
us-gaap Net Income Loss
NetIncomeLoss
18303000
us-gaap Net Income Loss
NetIncomeLoss
-3128000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67133205
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62024175
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67133205
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62024175
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7392000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1482000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18829000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
373396000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-250000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2426000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
370720000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
739000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1900000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
373359000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1078000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1559000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-262000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
262141000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2490000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2662000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-7000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
13491000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
280777000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2167000
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
122673000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
1141000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14999000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
391759000
us-gaap Profit Loss
ProfitLoss
18303000
us-gaap Profit Loss
ProfitLoss
-3128000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
132000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
45000
us-gaap Share Based Compensation
ShareBasedCompensation
2099000
us-gaap Share Based Compensation
ShareBasedCompensation
5755000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
180000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
65000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
32180000
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
22592000
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
23275000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1006000
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-446000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
748000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1094000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2481000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2821000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16045000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15494000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27000
gato Payments For Proceeds From Acquire Interest In Subsidiaries And Affiliates
PaymentsForProceedsFromAcquireInterestInSubsidiariesAndAffiliates
7365000
gato Payments For Proceeds From Acquire Interest In Subsidiaries And Affiliates
PaymentsForProceedsFromAcquireInterestInSubsidiariesAndAffiliates
261439000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261439000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
13000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7274000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
132873000
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
1027000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-441000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139185000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8653000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-137748000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15269000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12398000
us-gaap Interest Paid Net
InterestPaidNet
385000
us-gaap Interest Paid Net
InterestPaidNet
67000
gato Director Fess Converted To Deferred Share Units
DirectorFessConvertedToDeferredShareUnits
1141000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
683000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
575000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
387000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2976000
CY2022Q3 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2021Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1077000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
887000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
361000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
623000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1086000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
587000
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2334000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6520000
CY2022Q3 us-gaap Assets
Assets
388423000
CY2021Q3 us-gaap Assets
Assets
408385000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1700000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
739000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2329000
us-gaap Share Based Compensation
ShareBasedCompensation
2099000
us-gaap Share Based Compensation
ShareBasedCompensation
5755000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4862000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1900000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-14999000
us-gaap Net Income Loss
NetIncomeLoss
18303000
us-gaap Net Income Loss
NetIncomeLoss
-3128000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67133205
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62024175
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67133205
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62024175
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2021Q3 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
100000000
CY2021Q3 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
13000000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
442000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
442000
CY2021Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
9000000
CY2021Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
9000000
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
142000
us-gaap Interest Expense Debt
InterestExpenseDebt
368000
CY2022Q4 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
50000000
CY2022Q3 gato Line Of Credit Facility Contingent Increase Aggregate Maximum Borrowing Capacity
LineOfCreditFacilityContingentIncreaseAggregateMaximumBorrowingCapacity
25000000
CY2021Q3 us-gaap Exploration Expense
ExplorationExpense
479000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5933000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7244000
CY2022Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
31000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6801000
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1600000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1076000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8845000
CY2022Q3 us-gaap Assets
Assets
388423000
CY2021Q3 us-gaap Assets
Assets
408385000
us-gaap Exploration Expense
ExplorationExpense
110000
us-gaap Exploration Expense
ExplorationExpense
1397000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16967000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17758000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
132000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
45000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
32180000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22592000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3332000
CY2022Q2 us-gaap Dividends
Dividends
9975000

Files In Submission

Name View Source Status
0001104659-23-038837-index-headers.html Edgar Link pending
0001104659-23-038837-index.html Edgar Link pending
0001104659-23-038837.txt Edgar Link pending
0001104659-23-038837-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20220930.xsd Edgar Link pending
gato-20220930x10q.htm Edgar Link pending
gato-20220930x10q003.jpg Edgar Link pending
gato-20220930xex31d1.htm Edgar Link pending
gato-20220930xex31d2.htm Edgar Link pending
gato-20220930xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gato-20220930_lab.xml Edgar Link unprocessable
gato-20220930_def.xml Edgar Link unprocessable
gato-20220930_pre.xml Edgar Link unprocessable
gato-20220930x10q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gato-20220930_cal.xml Edgar Link unprocessable